Tyra Biosciences, Inc.
TYRA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001863127
In the last 90 days, Tyra Biosciences, Inc. insiders filed 1 open-market purchase and 0 sales; 168 institutions reported holding it in 13F filings for Q2 2026, worth $2.22B in total; no superinvestor holds it.
Q4 2024 vs. Q3 2024
How the institutions holding Tyra Biosciences, Inc. changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Q4 2024 | Change |
|---|---|---|---|
| Holders | 95 | 113 | +18 |
| Shares | 47.1M | 48.6M | +1.56M (+3.3%) |
| Value | $1.11B | $675.8M | −$430.2M (−38.9%) |
New holders (36)
Institutions that held Tyra Biosciences, Inc. at the end of Q4 2024 but not at the end of Q3 2024.
Sold out (18)
Institutions that held Tyra Biosciences, Inc. at the end of Q3 2024 and filed for Q4 2024 without it.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Boxer Capital, LLC | 6,448,359 | $151.6M |
| Frazier Life Sciences Management, L.P. | 731,020 | $17.2M |
| Perceptive Advisors LLC | 511,226 | $12.0M |
| Jennison Associates LLC | 158,187 | $3.72M |
| Tang Capital Management LLC | 150,000 | $3.53M |
| Ensign Peak Advisors, Inc | 115,616 | $2.72M |
| Woodline Partners LP | 55,866 | $1.31M |
| D. E. Shaw & Co., Inc. | 32,003 | $752.4K |
| Jane Street Group, LLC | 31,003 | $728.9K |
| Cinctive Capital Management LP | 22,900 | $538.4K |
| Options Solutions, LLC | 21,023 | $494.3K |
| Valence8 US LP | 13,188 | $310.1K |
| Balyasny Asset Management LLC | 12,988 | $305.3K |
| Mariner, LLC | 9,269 | $217.9K |
| Acadian Asset Management LLC | 848 | $19.0K |
| nVerses Capital, LLC | 400 | $9.40K |
| SRS Capital Advisors, Inc. | 7 | $165 |
| Capital Performance Advisors LLP | 5 | $118 |